Pulmonary disease in the acquired immune deficiency syndrome.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000276:immunology; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000209:etiology*; D008172:Lung Diseases, Fungal / Q000209:etiology*; D008206:Lymphatic Diseases / Q000209:etiology; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000209:etiology; D010419:Pentamidine / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014397:Tuberculosis, Pulmonary / Q000209:etiology
D004338:Drug Combinations; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole